New Covenant Trust Company’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$629K Buy
4,289
+335
+8% +$60.7K 0.47% 38
2026
Q1
$582K Buy
3,954
+730
+23% +$119K 0.52% 33
2025
Q4
$631K Buy
3,224
+82
+3% +$19.5K 0.57% 30
2025
Q3
$884K Sell
3,142
-154
-5% -$39.2K 0.82% 25
2025
Q2
$693K Hold
3,296
0.62% 29
2025
Q1
$464K Buy
3,296
+2
+0.1% +$326 0.49% 39
2024
Q4
$550K Sell
3,294
-205
-6% -$36.4K 0.55% 34
2024
Q3
$590K Hold
3,499
0.57% 34
2024
Q2
$485K Sell
3,499
-106
-3% -$13.2K 0.56% 33
2024
Q1
$453K Buy
+3,605
New +$413K 0.45% 36

Other funds holding ORCL

New Covenant Trust Company's ORCL Position: Q2 2026 in Review

New Covenant Trust Company increased its Oracle (ORCL) stake by 8.5% in Q2 2026, buying an estimated $60.7K and bringing the position to 4,289 shares worth $629K. The position accounts for 0.47% of the portfolio, ranked #38.

New Covenant Trust Company first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $884K in Q3 2025. 1,263 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • New Covenant Trust Company held 4,289 shares of Oracle worth $629K as of Q2 2026.
  • New Covenant Trust Company bought 335 Oracle shares in Q2 2026, an estimated $60.7K.
  • Oracle made up 0.47% of New Covenant Trust Company's portfolio in Q2 2026, its #38 holding.
  • New Covenant Trust Company first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • New Covenant Trust Company's Oracle position peaked at $884K in Q3 2025.
  • 1,263 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.